The U.S. FDA approved the first and only drug to treat people with advanced non-small cell lung cancer (NSCLC) whose tumors express the ROS1+ mutation....
Free Cancer Screening Guidelines
Research by NFCR Scientists Reveals New Insights into Treatment Resistance of Metastatic Breast Cancer
Oscillating expression of a key cancer gene may impact treatment approaches for patients NFCR-supported scientist Dr. Daniel Haber and his team at the Massachusetts General Hospital Cancer Center have identified a dynamic gene expression in metastatic breast cancer that may contribute to disease progression and resistance to treatment experienced by many…...
Genetic Sequencing and Diagnosis Sets a Guinness World Record
Can you imagine that a Guinness world record could be related to genetic sequencing and disease diagnosis? A world record for fastest genetic diagnosis was recently set by Dr. Stephen Kingsmore, president and CEO of Rady Children’s Institute for Genomic Medicine. Dr. Kingsmore is able to successfully diagnose critically ill…...
The First Successful Clinical Trial
Clinical Trial and translational medicine. Our CEO and son of the Founder of NFCR likes to talk history. Franklin C. Salisbury, Jr. notes the coincidence, perhaps, that the Salisbury name has long been associated with unheralded basic research that leads to major breakthroughs. Clinical trial and translational medicine – bring…...
Breast Cancer Treatments in the News
New Treatments Could Shrink Breast Cancer in Just 11 Days For patients with HER2-positive breast cancer, a new combination therapy with two drugs could shrink or even eliminate their tumors in just 11 days. About 10% of breast cancers are HER2-positive, which is a subtype of breast cancer that is aggressive…...
DOWNLOAD
